• In early May 2026, Onto Innovation Inc. reported first-quarter 2026 results showing sales of US$291.95 million, higher than a year earlier, but with net income dropping to US$33.75 million and diluted earnings per share from continuing operations easing to US$0.67.
• At the same time, the company issued second-quarter 2026 guidance calling for US$320 million to US$330 million in revenue and GAAP diluted earnings per share of US$1.09 to US$1.18, highlighting management’s confidence despite the year-on-year profit contraction.
• With management projecting higher second-quarter revenue and earnings, we’ll now examine how this guidance affects Onto Innovation’s existing investment narrative.

AI is about to change healthcare. These 34 stocks are working on everything from early diagnostics to drug discovery. The best part - they are all under $10b in market cap - there's still time to get in early.

Onto Innovation Investment Narrative Recap

To own Onto Innovation today, you need to believe its tools will stay essential to advanced semiconductor packaging even as customer spending and margins swing. The latest quarter showed stronger sales but weaker earnings, so the key near term catalyst remains execution on the guided second quarter revenue and margin lift, while the biggest ongoing risk is that any delay in AI and advanced node demand could prolong profit pressure. So far, this update does not materially change that balance.

Among recent announcements, the raised second quarter 2026 guidance to US$320 million to US$330 million in revenue and GAAP EPS of US$1.09 to US$1.18 is most relevant. It connects directly to the investment case that Onto can translate interest in platforms like Dragonfly into near term earnings progress, while also testing whether the company can sustain higher operating margins in the face of tariffs and concentrated customer exposure.

But against this improving guidance, you should also consider the risk that heavier reliance on a few AI packaging customers leaves Onto more exposed if spending slows or shifts...

Onto Innovation's narrative projects $1.7 billion revenue and $428.9 million earnings by 2029.

Uncover how Onto Innovation's forecasts yield a $280.71 fair value, in line with its current price.

Exploring Other Perspectives

Some of the most optimistic analysts were already assuming Onto could reach about US$1.8 billion in revenue and over US$700 million in earnings by 2029, which is far more upbeat than the baseline view and the customer concentration risk you just read about, so this new guidance may either support that very bullish path or force a rethink of how realistic those higher targets really are.

Explore 5 other fair value estimates on Onto Innovation - why the stock might be worth as much as $280.71!

Reach Your Own Conclusion

Don't just follow the ticker - dig into the data and build a conviction that's truly your own.

• A great starting point for your Onto Innovation research is our analysis highlighting 2 key rewards and 2 important warning signs that could impact your investment decision.
• Our free Onto Innovation research report provides a comprehensive fundamental analysis summarized in a single visual - the Snowflake - making it easy to evaluate Onto Innovation's overall financial health at a glance.

Want Some Alternatives?

Our top stock finds are flying under the radar-for now. Get in early:

• We've uncovered the 12 dividend fortresses yielding 5%+ that don't just survive market storms, but thrive in them.
• The future of work is here. Discover the 33 top robotics and automation stocks leading the charge in AI-driven automation and industrial transformation.
• Invest in the nuclear renaissance through our list of 91 elite nuclear energy infrastructure plays powering the global AI revolution.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.